Rationale for Targeted Therapy Toward BTK in B-Cell Malignancies

In this downloadable slideset, John C. Byrd, MD, provides the rationale for targeting BTK with inhibitors in patients with B-cell malignancies.
John C. Byrd, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 954 KB
Released: June 5, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
AstraZeneca

Related Content

Expert-authored commentary on the utility of BTK inhibitors in the care of patients with Waldenström macroglobulinemia from CCO

person default Prashant Kapoor, MD Released: March 31, 2020

Interactive online tool providing expert treatment recommendations for relapsed/refractory follicular lymphoma from CCO

John M. Burke, MD Ian W. Flinn, MD, PhD Christopher R. Flowers, MD, MS John P. Leonard, MD Jeff P. Sharman, MD Released: March 25, 2020

Expert slides from CCO on CAR T-cells: optimizing patients for therapy, toxicity management, patient education, promising investigational strategies.

Matthew J. Frigault, MD Released: March 24, 2020

In this commentary, experts answer questions from a recent Clinical Care Options symposium on CAR T-cell therapy

Jae H. Park, MD Released: March 24, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?